The 143-year-old firm will occupy half of the building's massive second floor, with its own cafeteria and lounge, custom bar ...

The successful development of Frexalimab could positively impact Sanofi’s stock performance by enhancing its portfolio in the multiple sclerosis market, potentially increasing investor interest. As ...

Hidradenitis suppurativa is associated with a higher risk for new-onset depression and anxiety, which may occur despite ...

Itching is often the most debilitating cutaneous symptom of CKD and ESRD. Experts recommend a stepwise treatment approach ...

Owing to Briumvi's solid launch, TG's balance sheet is in excellent condition. Despite new competition, Briumvi's five-year ...

"Cognition Therapeutics’ drug shows 129% cognitive decline arrest in mild Alzheimer’s" was originally created and published ...

From concerning statistics on global health outcomes to new insights on AI and RWD, explore the top pharma news from July ...

Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for SAR446523, an ...

Multiple myeloma pathogenesis is marked by incredibly complex processes that range beyond primary or acquired genetic alterations, with factors in the ...

Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma ...